• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2000 Fiscal Year Final Research Report Summary

Study on pathophysiological mechanism of autoantibody production in pemphigus

Research Project

Project/Area Number 11470185
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section一般
Research Field Dermatology
Research InstitutionKeio University

Principal Investigator

AMAGAI Masayuki  Keio University School of Medicine, Assistant Professor, 医学部, 専任講師 (90212563)

Co-Investigator(Kenkyū-buntansha) HARUMI Suzuki  Keio University School of Medicine, Assistant Professor, 医学部, 専任講師 (70235985)
KOYASU Shigeo  Keio University School of Medicine, Professor, 医学部, 教授 (90153684)
NISHIKAWA Takeji  Keio University School of Medicine, Professor, 医学部, 教授 (50051579)
Project Period (FY) 1999 – 2000
Keywordsautoimmune diseases / pemphigus / animal model / desmoglein / autoantibody / tolerance / B cell / knockout mouse
Research Abstract

Mechanisms of tolerance break against desmoglein 3 (Dsg3) in patients with pemphigus vulgaris (PV) producing pathogenic anti-Dsg3 IgG autoantibodies are unclear. In this study, we had dual approaches using human materials of PV patients and a mouse model for PV.To examine cellular mechanisms underlying the autoantibody production in PV patients, we have successfully developed an Enzyme-Linked Immunospot (ELISPOT) assay which was able to detect Dsg3-specific autoimmune B cells quantitatively. The in vitro anti-Dsg3 Ab production was abolished when CD4^+ cells were depleted or when anti-HLA-DR or anti-HLA-DQ monoclonal Ab was added to the cultures, suggesting the important role of HLA class II-restricted CD4^+ T cells in the autoAb production in PV.Using a novel PV mouse model involving Dsg3 knockout mice, we investigated the mechanisms of tolerance loss against Dsg3. Adoptive transfer of Dsg3^<-/-> splenocytes immunized with recombinant mouse Dsg3 to Rag2^<-/-> recipient mice expressing Dsg3 resulted in the stable production of anti-Dsg3 IgG and development of PV phenotypes including oral erosions with suprabasilar acantholysis. When purified T and B cells from Dsg3^<-/->, Dsg3^<+/-> or Dsg3^<+/+> mice were mixed with various combinations and transferred to Rag2^<-/-> mice, pathogenic anti-Dsg3 IgG production was observed only with a combination of Dsg3^<-/-> T and Dsg3^<-/-> B cells but not with the other combinations. These results suggest that loss of tolerance against Dsg3 in both B and T cells is important for the development of autoimmune state of PV.

  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] Mahoney MG,Wang Z,Rothenberger KL,Koch PJ,Amagai M,Stanley JR: "Explanation for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris."J Clin Invest. 103. 461-468 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nishifuji K,Amagai M,Kuwana M,Iwasaki T,Nishikawa T: "Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot (ELISPOT) Assay : requirement of T cell collaboration for autoantibody production."J Invest Dermatol. 114. 88-94 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Amagai M,Tsunoda K,Suzuki H,Nishifuji K,Koyasu S,Nishikawa T: "Use of autoantigen knockout mice to develop an active autoimmune disease model of pemphigus."J Clin Invest. 105. 625-631 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Wu H,Wang ZH,Yan A,Lyle S,Fakbarzadeh S,Wahl JK,Wheelock MJ,Ishikawa H,Uitto J,Amagai M,Stanley JR: "Protection against pemphigus foliaceus by desmoglein 3 in neonates."N Eng J Med. 343. 31-35 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Futei Y,Amagai M,Sekiguchi M,Nishifuji K,Fujii Y,Nishikawa T: "Conformational eptiope mapping of desmoglein 3 using domain-swapped molecules in pemphigus vulgaris."J Invest Dermatol. 115. 829-834 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Amagai M,Matsuyoshi N,Wang ZH,Andl C,Stanley JR: "Toxin in bullous impetigo and staphylococcal scalded skin syndrome targets desmoglein 1."Nature Medicine. 6. 1275-1277 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 天谷雅行: "免疫学がわかる"羊土社. 123 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Mahoney MG, Wang Z, Rothenberger KL, Koch PJ, Amagai M, Stanley JR: "Explanation for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris."J Clin Invest. 103. 461-468 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nishifuji K, Amagai M, Kuwana M, Iwasaki T, Nishikawa T: "Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot (ELISPOT) Assay : requirement of T cell collaboration for autoantibody production."J Invest Dermatol. 114. 88-94 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Amagai M, Tsunoda K, Suzuki H, Nishifuji K, Koyasu S, Nishikawa T: "Use of autoantigen knockout mice to develop an active autoimmune disease model of pemphigus."J Clin Invest. 105. 625-631 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Wu H, Wang ZH, Yan A, Lyle S, Fakharzadeh S, Wahl JK, Wheelock MJ, Ishikawa H, Uitto J, Amagai M, Stanley JR: "Protection against pemphigus foliaceus by desmoglein 3 in neonates."N Eng J Med. 343. 31-35 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Futei Y, Amagai M, Sekiguchi M, Nishifuji K, Fujii Y, Nishikawa T: "Conformational eptiope mapping of desmoglein 3 using domain-swapped molecules in pemphigus vulgaris."J Invest Dermatol. 115. 829-834 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR: "Toxin in bullous impetigo and staphylococcal scalded skin syndrome targets desmoglein 1."Nature Medicine. 6. 1275-1277 (2000)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi